Literature DB >> 707340

Hormonal and metabolic responses to intravenous glucose in children on regular hemodialysis.

M M El-Bishti, R Counahan, S R Bloom, C Chantler.   

Abstract

Blood glucose, plasma nonesterified fatty acids, amino acids, immunoreactive insulin, growth hormone, and immunoreactive glucagon responses to intravenous glucose were determined in 16 children on regular hemodialysis for chronic renal failure and nine healthy children. In the patients the fractional disappearance rate of glucose was significantly reduced, basal immunoreactive insulin was significantly raised, and while the early immunoreactive insulin response to glucose was similar in patients and controls, the late response was increased. Basal growth hormone was elevated in the patients and rose paradoxically following glucose. Fasting immunoreactive glucagon was significantly higher in the patients and was not suppressed by glucose. Plasma nonesterified fatty acid levels were lower in the patients and fell more markedly after glucose. Alanine levels, which were significantly raised in those with poor glucose tolerance, fell to normal after glucose and did not vary in those with more normal glucose tolerance. It is speculated that the metabolic and hormonal alterations may be interrelated and result from failure of normal glucose utilization.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 707340     DOI: 10.1093/ajcn/31.10.1865

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

Review 1.  Carbohydrate metabolism in uremia.

Authors:  R H Mak
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

2.  Insulin-like growth factor-1, growth hormone-dependent insulin-like growth factor-binding protein and growth in children with chronic renal failure.

Authors:  E M Hodson; A S Brown; L P Roy; A R Rosenberg
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

Review 3.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

4.  Effects of growth hormone therapy and malnutrition on the growth of rats with renal failure.

Authors:  D R Powell; R G Rosenfeld; R L Hintz
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

5.  Plasma growth hormone-binding activity is low in uraemic children.

Authors:  M C Postel-Vinay; A Tar; H Crosnier; M Broyer; R Rappaport; B Tönshoff; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

6.  Insulin-like growth factor I values in patients on maintenance hemodialysis: relationship to growth hormone and albumin levels.

Authors:  A Caufriez; D Abramowicz; J L Vanherweghem; G Copinschi
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

Review 7.  Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failure.

Authors:  D R Powell; F Liu; B K Baker; P D Lee; R L Hintz
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.